The use of intravitreal ranibizumab for choroidal neovascularization associated with Vogt-Koyanagi-Harada syndrome

Case Reports in Medicine

Volumn 2011, Issue , 2011, Pages

  Kolomeyer, A M ^a   Roy, M S ^a   Chu, D S ^a  

^a INSTITUTE OF OPHTHALMOLOGY AND VISUAL SCIENCE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; METHOTREXATE; PREDNISONE; RANIBIZUMAB;

ADULT; ARTICLE; CASE REPORT; EYE INFLAMMATION; EYE PAIN; FEMALE; FLUORESCENCE ANGIOGRAPHY; HUMAN; IRITIS; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; RETINA DETACHMENT; SUBRETINAL NEOVASCULARIZATION; VISUAL ACUITY; VITRITIS; VOGT KOYANAGI SYNDROME;

EID: 84883572696     PISSN: 16879627     EISSN: 16879635     Source Type: Journal    
DOI: 10.1155/2011/747648     Document Type: Article

References (12)

1. Maezawa N., Yano A., Taniguchi M., Kojima S., The role of cytotoxic T lymphocytes in the pathogenesis of Vogt-Koyanagi-Harada disease Ophthalmologica 1982 185 3 179 186 (Pubitemid 12031627)
2. Perry H. D., Font R. L., Clinical and histopathologic observations in severe Vogt Koyanagi Harada syndrome American Journal of Ophthalmology 1977 83 2 242 254 (Pubitemid 8041931)
3. Lertsumitkul S., Whitcup S. M., Nussenblatt R. B., Chan C. C., Subretinal fibrosis and choroidal neovascularization in Vogt-Koyanagi-Harada syndrome Graefe's Archive for Clinical and Experimental Ophthalmology 1999 237 12 1039 1045 (Pubitemid 30021296)
4. Moorthy R. S., Chong L. P., Smith R. E., Rao N. A., Subretinal neovascular membranes in Vogt-Koyanagi-Harada syndrome American Journal of Ophthalmology 1993 116 2 164 170 (Pubitemid 23229076)
5. Grossniklaus H. E., Ling J. X., Wallace T. M., Dithmar S., Lawson D. H., Cohen C., Elner V. M., Elner S. G., Sternberg P., Macrophage and retinal pigment epithelium expression of angiogenic cytokines in choroidal neovascularization Molecular Vision 2002 8 119 126 (Pubitemid 36153599)
6. Chan W. M., Lai T. Y. Y., Liu D. T. L., Lam D. S. C., Intravitreal bevacizumab (avastin) for choroidal neovascularization secondary to central serous chorioretinopathy, secondary to punctate inner choroidopathy, or of idiopathic origin American Journal of Ophthalmology 2007 143 6 977 983
7. Arias L., Planas N., Prades S., Caminal J. M., Rubio M., Pujol O., Roca G., Intravitreal bevacizumab (Avastin) for choroidal neovascularisation secondary to pathological myopia: 6-month results British Journal of Ophthalmology 2008 92 8 1035 1039
8. Tran T. H. C., Fardeau C., Terrada C., Ducos De Lahitte G., Bodaghi B., Lehoang P., Intravitreal bevacizumab for refractory choroidal neovascularization (CNV) secondary to uveitis Graefe's Archive for Clinical and Experimental Ophthalmology 2008 246 12 1685 1692
9. Vadal M., Pece A., Cipolla S., Monteleone C., Fasolino G., Casuccio A., Cillino S., Is ranibizumab effective in stopping the loss of vision for choroidal neovascularisation in pathologic myopia? A long-term follow-up study British Journal of Ophthalmology 2011 95 5 657 661
10. Wu L., Evans T., Saravia M., Schlaen A., Couto C., Intravitreal bevacizumab for choroidal neovascularization secondary to Vogt-Koyanagi-Harada syndrome Japanese Journal of Ophthalmology 2009 53 1 57 60
11. Nowilaty S. R., Bouhaimed M., Photodynamic Therapy Study Group, Photodynamic therapy for subfoveal choroidal neovascularisation in Vogt-Koyanagi-Harada disease British Journal of Ophthalmology 2006 90 8 982 986 (Pubitemid 44140177)
12. Soheilian M., Movaseghi M., Ramezani A., Peyman G. A., Pilot study of safety and effect of combined intravitreal bevacizumab and methotrexate for neovascular age-related macular degeneration European Journal of Ophthalmology 2011 21 1 77 82